Brief: Akero Therapeutics Reports Q3 2024 Financial Results And Provides Business Update
08/11/2024 12:24
Nov 8 (Reuters) - Akero Therapeutics Inc AKRO.O :
* AKERO THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* AKERO THERAPEUTICS INC: QTRLY NET LOSS PER SHARE $1.05
Source text: ID:nGNX8pDDs9
Further company coverage: AKRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk